Paper-based analytical devices (PADs) have shown great promise for point-of-care testing
and on-site detection of analytes with chemical, biochemical, and environmental importance …

Cancer is one of the main causes of mortality and morbidity worldwide. However, its early
non-invasive detection via quantification of appropriate biomarkers can significantly reduce …

Extensive medical research showed that patients, with high protein concentration in urine,
have various kinds of kidney diseases, referred to as proteinuria. Urinary protein biomarkers …

Lateral flow assays (LFAs) provide some of the most attractive point-of-care instruments for
broad applications with simple, rapid, user-friendly, and cost-effective characteristics …

Chemiluminescence (CL) and bioluminescence (BL) imaging technologies, which require
no external light source so as to avoid the photobleaching, background interference and …

Paper-based lateral-flow immunoassays (LFIAs) have achieved considerable commercial
success and their impact in diagnostics is continuously growing. LFIA results are often …

Exposure to mycotoxins, which may contaminate food and feed commodities, represents a
serious health risk for consumers. Ochratoxin A (OTA) is one of the most abundant and toxic …

Introduction: The development of point-of-care testing (POCT) has made clinical diagnostics
available, affordable, rapid, and easy to use since the 1990s. The significance of this …

The development of smartphone–based biosensors for point-of-care testing (POCT)
applications allows realizing “all in one” instruments, with large potential distribution among …

Immunoassays whose readouts rely on chemiluminescence are increasingly useful for a
broad range of analytical applications, but they are rarely made into point-of-care (POC) …